Treace John T.
Transaction: 06/11/2026
BUY
Change
+9,891
Price
$4.04
Filing
06/12/2026
Type
BUY
Treace Medical Concepts, Inc.
TMCI • Medical - Devices
$4.81
▼ -0.07 (-1.43%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$312.89M
Growth
27.8%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 17.9%Manageable debt level · 0.16Healthy liquidity · 4.31Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 9, 2026, 12:12 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.81
Change-1.43%
Shares Out65.05M
Market Cap$312.89M
Enterprise Value$280.36M
52W Range1.17 - 7.78
Beta1.38
P/E-5.26
P/S1.52
P/B4.62
P/FCF-12.49
EV/Sales1.37
Price$4.81
Change-1.43%
Shares Out65.05M
Market Cap$312.89M
Enterprise Value$280.36M
52W Range1.17 - 7.78
Beta1.38
P/E-5.26
P/S1.52
P/B4.62
P/FCF-12.49
EV/Sales1.37
EV/EBITDA-5.77
EV/FCF-11.19
Earnings Yield-19.02%
FCF Yield-8.00%
Dividend Yield0.00%
Gross Margin79.81%
Oper. Margin-25.46%
Profit Margin-27.74%
Debt/Eq0.16
Current Ratio4.31
Quick Ratio3.13
Revenue 5Y27.83%
Target$8.60
Target Upside78.79%
Target Median$6.50
Target Range3.00 - 16.00
Volume879.95K
Avg Volume734.25K
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
55
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
92/100
Why this score▼
Positive revenue growth · 17.9%Manageable debt level · 0.16Healthy liquidity · 4.31Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
56/100
Neutral
Bullish
2
Hold
6
Bearish
1
Price Target
2026-08-09
Low
$3.00
Mean
$8.60
Median
$6.50
High
$16.00
Insider Transactions
Recent executive and insider activity
Treace John T.
Transaction: 06/10/2026
BUY
Change
+14,715
Price
$4.02
Filing
06/12/2026
Type
BUY
Treace John T.
Transaction: 06/11/2026
BUY
Change
+22,887
Price
$4.04
Filing
06/11/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Treace John T. | BUY | +9,891 | $4.04 | 06/11/2026 | 06/12/2026 |
| Treace John T. | BUY | +14,715 | $4.02 | 06/10/2026 | 06/12/2026 |
| Treace John T. | BUY | +22,887 | $4.04 | 06/11/2026 | 06/11/2026 |
| Treace John T. | BUY | +29,430 | $4.02 | 06/10/2026 | 06/11/2026 |
| Treace John T. | BUY | +50,000 | $3.56 | 06/01/2026 | 06/01/2026 |
| Treace John T. | BUY | +61,202 | $3.02 | 05/28/2026 | 05/28/2026 |
| Treace John T. | BUY | +49,810 | $2.87 | 05/27/2026 | 05/28/2026 |
| Treace John T. | BUY | +4,508 | $2.79 | 05/26/2026 | 05/28/2026 |
| Hanna Betsy | BUY | +30,000 | Not reported | 05/19/2026 | 05/19/2026 |
| HAMILTON LAWRENCE W | BUY | +30,000 | Not reported | 05/19/2026 | 05/19/2026 |
| Jain Deepti | BUY | +30,000 | Not reported | 05/19/2026 | 05/19/2026 |
| Berry Lance A | BUY | +30,000 | Not reported | 05/19/2026 | 05/19/2026 |
| Kiernan Jane E | BUY | +30,000 | Not reported | 05/19/2026 | 05/19/2026 |
| BAKEWELL JOHN K | BUY | +30,000 | Not reported | 05/19/2026 | 05/19/2026 |
| Treace John T. | BUY | +61,750 | $2.62 | 05/14/2026 | 05/14/2026 |
| Treace John T. | BUY | +49,013 | $2.46 | 05/13/2026 | 05/14/2026 |
| Treace John T. | BUY | +43,000 | $2.17 | 05/12/2026 | 05/14/2026 |
| Hair Mark | SELL | -11,547 | Not reported | 04/17/2026 | 04/20/2026 |
| Hair Mark | BUY | +100,000 | Not reported | 04/01/2026 | 04/03/2026 |
| Hair Mark | SELL | -3,695 | Not reported | 03/10/2026 | 03/11/2026 |